Diabetes Drug Quiz: Do You Know Your Generics vs Trades?

Article

Trade names often mask the essential nature of a medication, but some of the new agents that treat type 2 diabetes take it to a new level. Here, 5 chances to see what you know.

1. Canagliflozin is the generic name for:

A. Bydureon

B. Invokamet

C. Invokana

D. Jardiance

Click for answer and next question

 

 

Answer: C. Invokana

 

 

2. Xigduo combines which of the following antihyperglycemic agents:

A. Metformin/dapagliflozin

B. Metformin/canagliflozin

C. Linagliptin/empagliflozin

D. Jardiance/saxagliptin

Click for answer and next question

 

 

Answer: A. Metformin/dapagliflozin

 

 

3. Which of the following SGLT2 inhibitors goes by the trade name Farxiga?

A. Canagliflozin

B. Dapagliflozin

C. Empagliflozin

Click for answer and next question

 

Answer: B. Dapagliflozin

 

4. When you combine linagliptin and empagliflozin, you get:

A. Jardiance

B. Invokana

C. Glyxambi

D. Xigduo

Click for answer and next question

 

 

Answer: C. Glyxambi

 

 

5. The trade name Jardiance refers to which of the following?  

A. Tanzeum

B. Canagliflozin

C. Dulaglutide

D. Empagliflozin

Click for answer and next question

 

 

Answer: D. Empagliflozin

 

 

One for good measure. The trade name of the drug that combines metformin and dapagliflozin is:

A. Trulicity

B. Invokamet

C. Farxiga

D. Xigduo

Click for answer and quiz grade

 

 

Answer: D. Xigduo

 

Grades

5 correct: A+  You've been paying attention!

4 correct: B     Pretty sharp

3 correct: C     Average Joe

2 correct: D    Start carrying a laminated cheat sheet

1 correct: F     Nearby P & T notified

0 corrrect:      Remedial pharmacy tutoring for you!

 

 

 

 

 

 

 

 

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
© 2024 MJH Life Sciences

All rights reserved.